Thus, the aberrant release of IL1β is involved in the pathogenesis of a range of inflammatory diseases, such as gout, type II diabetes, atherosclerosis, obesity, heart failure, recurrent pericarditis, rheumatoid arthritis and smoldering myeloma [40]. The gene discussed is IL1B; the disease is obesity disorder.